Skip Ribbon Commands
Skip to main content
Sign In

26174 Anser VDZ, Prometheus (3180)

Anser VDZ, Prometheus (3180)
Test Code: PVDZSO
Synonyms/Keywords

Vedolizumab

Test Components

Serum ​vedolizumab drug concentration  and antibodies to vedolizumab levels 

Useful For

Determining personalized solutions for managing loss of response to vedolizumab

Quantifying whether inflammatory bowel disease patients have antibodies and/or sufficient drug concentrations

Measuring antibodies in the presence of drugs (i.e., drug tolerant assay)

Specimen Requirements
Fasting RequiredSpecimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Serum​Serum Separator Tube (SST)​Red Top Tube (RTT)​2 mL​0.5 mL
Collection Processing Instructions

​Send ambient or refrigerated (cold pack acceptable).  ​Do not freeze.

Specimen Stability Information
Specimen TypeTemperatureTime
​Serum​Ambient​7 days
​Refrigerated (preferred) ​9 days
Rejection Criteria
Frozen Samples
Performing Laboratory Information
Performing LocationDay(s) Test PerformedAnalytical TimeMethodology/Instrumentation
​Prometheus Laboratories, Inc.​Monday through Friday​3 daysNonradio-labeled liquid-phase mobility shift assay
Reference Lab
Synonyms/Keywords

Vedolizumab

Test Components

Serum ​vedolizumab drug concentration  and antibodies to vedolizumab levels 

Ordering Applications
Ordering ApplicationDescription
​COM​Anser VDZ, Prometheus (3180)
​Cerner​Anser VDZ, Prometheus (3180)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting RequiredSpecimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Serum​Serum Separator Tube (SST)​Red Top Tube (RTT)​2 mL​0.5 mL
Collection Processing

​Send ambient or refrigerated (cold pack acceptable).  ​Do not freeze.

Specimen Stability Information
Specimen TypeTemperatureTime
​Serum​Ambient​7 days
​Refrigerated (preferred) ​9 days
Rejection Criteria
Frozen Samples
Useful For

Determining personalized solutions for managing loss of response to vedolizumab

Quantifying whether inflammatory bowel disease patients have antibodies and/or sufficient drug concentrations

Measuring antibodies in the presence of drugs (i.e., drug tolerant assay)

Test Components

Serum ​vedolizumab drug concentration  and antibodies to vedolizumab levels 

For more information visit:
Performing Laboratory Information
Performing LocationDay(s) Test PerformedAnalytical TimeMethodology/Instrumentation
​Prometheus Laboratories, Inc.​Monday through Friday​3 daysNonradio-labeled liquid-phase mobility shift assay
Reference Lab
For billing questions, see Contacts
For most current information refer to the Marshfield Laboratory online reference manual.